000 03327nam a22005175i 4500
001 978-0-387-29346-2
003 DE-He213
005 20161121230635.0
007 cr nn 008mamaa
008 100301s2006 xxu| s |||| 0|eng d
020 _a9780387293462
_9978-0-387-29346-2
024 7 _a10.1007/978-0-387-29346-2
_2doi
050 4 _aRC254-282
072 7 _aMJCL
_2bicssc
072 7 _aMED062000
_2bisacsh
082 0 4 _a616.994
_223
245 1 0 _aHodgkin’s and Non-Hodgkin’s Lymphoma
_h[electronic resource] /
_cedited by John P. Leonard, Morton Coleman.
264 1 _aBoston, MA :
_bSpringer US,
_c2006.
300 _aXII, 476 p.
_bonline resource.
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
347 _atext file
_bPDF
_2rda
490 1 _aCancer Treatment and Research,
_x0927-3042 ;
_v131
505 0 _aPathology of B-Cell Non-Hodgkin’s Lymphomas and Multiple Myeloma -- Pathogenesis of Viral Lymphomas -- The Indolent B-Cell Lymphomas -- Diffuse Large B-Cell NHL -- Mantle Cell Lymphoma: Current Concept in Biology and Treatment -- T-Cell Non-Hogdkin’s Lymphoma -- Monoclonal Antibodies in the Treatment of Non-Hodgkin’s Lymphoma -- Blood and Bone Marrow Transplantation for Patients with Hodgkin’s and Non-Hodgkin’s Lymphoma -- Vaccine Therapies for Non-Hodgkin’s Lymphomas -- Management of Early Stage Hodgkin’s Lymphoma -- Management of Advanced Stage Hodgkin’s Lymphoma -- Nodular Lymphocyte Predominant Hodgkin’s Disease -- Lymphoma Imaging: Nuclear Medicine -- Novel Small Molecules in the Treatment of Lymphomas.
520 _aOver recent years, there has been a dramatic increase in knowledge of the biology of the lymphomas which has been accompanied by the emergence of new treatments that offer both improvements in efficacy and reduction in toxicity. Molecular profiling of tumor tissue and other new advances have led to a better understanding of the genetic basis of lymphoma, identification of new therapeutic targets, and potentially valuable prognostic information. Monoclonal antibody therapies, radioimmunoconjugates and other new agents such as proteosome inhibitors are providing important new treatment options for patients. In this volume, an internationally recognized group of experts provides a comprehensive overview of the biology, pathology, standard treatments, and novel approaches in management of patients across the complex landscape of lymphoma subtypes. Researchers and practitioners alike will welcome this useful summary of the state of the art in this field.
650 0 _aMedicine.
650 0 _aInterventional radiology.
650 0 _aHematology.
650 0 _aOncology.
650 0 _aPathology.
650 1 4 _aMedicine & Public Health.
650 2 4 _aOncology.
650 2 4 _aHematology.
650 2 4 _aPathology.
650 2 4 _aInterventional Radiology.
700 1 _aLeonard, John P.
_eeditor.
700 1 _aColeman, Morton.
_eeditor.
710 2 _aSpringerLink (Online service)
773 0 _tSpringer eBooks
776 0 8 _iPrinted edition:
_z9780387293455
830 0 _aCancer Treatment and Research,
_x0927-3042 ;
_v131
856 4 0 _uhttp://dx.doi.org/10.1007/978-0-387-29346-2
912 _aZDB-2-SME
950 _aMedicine (Springer-11650)
999 _c501753
_d501753